<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">378926179</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180305123618.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">161128e20040617xx      s     000 0 mul  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1515/LabMed.2004.036</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)gruyter-10.1515/LabMed.2004.036</subfield>
  </datafield>
  <datafield tag="100" ind1="1" ind2=" ">
   <subfield code="a">Nichols</subfield>
   <subfield code="D">J.H.</subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="4">
   <subfield code="a">The history, advantages and limitations of point-of-care testing for blood glucose</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">Geschichte, Vorteile und Grenzen des Point-of-Care-Testing im Bereich der Blutzuckerkontrolle / [J.H. Nichols]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Glucose testing has evolved from primitive urine tasting and chemical tests to sophisticated enzymatic and biosensor technologies with computerized data recording capabilities. Glucose monitoring will become more important in the future, as the incidence of diabetes increases. Current meters allow for the rapid analysis of small amounts of blood in a variety of healthcare settings, but suffer from the instability and common interferences of their enzyme-based technologies. Although the performance of glucose meters is not yet as accurate as laboratory methods, glucose meters provide a reasonable estimate to base insulin management and trend glucose control. Glucose self-management delays the onset of diabetic complications and intensive monitoring of surgical inpatients improves patient outcome. Future research promises to develop less invasive and more continuous monitoring methods. While there is currently no cure for diabetes, the advent of glucose meters and monitoring technologies has provided new insights into the nature of the disease and made diabetes a more manageable disorder.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Copyright © 2004 by Walter de Gruyter GmbH &amp; Co. KG</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Medical equipment &amp; techniques</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Medical diagnosis</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Diseases &amp; disorders</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">LaboratoriumsMedizin</subfield>
   <subfield code="d">Walter de Gruyter</subfield>
   <subfield code="g">28/3(2004-06-17), 245-250</subfield>
   <subfield code="x">0342-3026</subfield>
   <subfield code="q">28:3&lt;245</subfield>
   <subfield code="1">2004</subfield>
   <subfield code="2">28</subfield>
   <subfield code="o">labm</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1515/LabMed.2004.036</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1515/LabMed.2004.036</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">100</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Nichols</subfield>
   <subfield code="D">J.H.</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">LaboratoriumsMedizin</subfield>
   <subfield code="d">Walter de Gruyter</subfield>
   <subfield code="g">28/3(2004-06-17), 245-250</subfield>
   <subfield code="x">0342-3026</subfield>
   <subfield code="q">28:3&lt;245</subfield>
   <subfield code="1">2004</subfield>
   <subfield code="2">28</subfield>
   <subfield code="o">labm</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="b">CC0</subfield>
   <subfield code="u">http://creativecommons.org/publicdomain/zero/1.0</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-gruyter</subfield>
  </datafield>
 </record>
</collection>
